Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure

Stephen Spellman, Robert Bray, Sandra Rosen-Bronson, Michael Haagenson, John Klein, Susan Flesch, Cynthia Vierra-Green, Claudio Anasetti

Blood (2010) 115 (13): 2704–2708.

https://doi.org/10.1182/blood-2009-09-244525

Published: 2010

Journal Articles

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

Sarah Cooley, Elizabeth Trachtenberg, Tracy L. Bergemann, Koy Saeteurn, John Klein, Chap T. Le, Steven G. E. Marsh, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller, Daniel J. Weisdorf

Blood (2009) 113 (3): 726–732.

https://doi.org/10.1182/blood-2008-07-171926

Published: 2009

Includes: Supplemental data

Journal Articles

Identifying Amino Acid Substitution Positions Associated with Day 100 Survival in Unrelated Donor Stem Cell Transplant Using Random Forest Analysis

Susana Marino, MD, PhD, Shang Lin, PhD, Martin Maiers, MS, Michael D Haagenson, MS, Stephen R Spellman, MS, Stephanie J. Lee, MD, MPH, Tao Wang, PhD, John Klein, PhD, Koen Van Besien, MD

Blood (2008) 112 (11): 3012.

https://doi.org/10.1182/blood.V112.11.3012.3012

Published: 2008

Journal Articles

Donor-Recipient Matching at the HLA-C Locus and Early Outcomes after Unrelated Umbilical Cord Blood Transplant (UCBT)

Mary Eapen, MBBS, John Klein, PhD, Guillermo Sanz, MD, PhD, Claudio Anasetti, MD, Joan Garcia, MD, Eliane Gluckman, MD, Mary M. Horowitz, MD, MS, Gesine Koegler, MD, Mary Laughlin, MD, Gerard Michel, MD, Stephen R Spellman, MS, Franklin O. Smith, MD, Vanderson Rocha, MD, PhD

Blood (2008) 112 (11): 153.

https://doi.org/10.1182/blood.V112.11.153.153

Published: 2008

Journal Articles

The Clinical Significance of Matching for Alleles at the Low Expression HLA Loci DP, DQ and DRB3/4/5 in Unrelated Hematopoietic Stem Cell Transplantation

Marcelo Fernandez-Vina, PhD, John Klein, PhD, Michael D Haagenson, MS, Stephen R Spellman, MS, Stephanie J. Lee, MD, MPH, Claudio Anasetti, MD, Lee Ann Baxter-Lowe, PhD, Pedro Cano, MD, Neal Flomenberg, MD, FACP, Mary M. Horowitz, MD, MS, Carolyn K Hurley, PhD, Machteld Oudshoorn, PhD, Effie W Petersdorf, MD, Michelle Setterholm, Richard Champlin, MD, Marcos De Lima, MD

Blood (2008) 112 (11): 561.

https://doi.org/10.1182/blood.V112.11.561.561

Published: 2008

Journal Articles

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

Ann E Woolfrey, MD, John Klein, PhD, Michael D Haagenson, MS, Stephen R Spellman, MS, Minoo Battiwalla, MD, James L. Gajewski, MD, Gregory A. Hale, MD, John Horan, MD, MPH, Carolyn K Hurley, PhD, Craig Kollman, PhD, Susana Marino, MD, PhD, Machteld Oudshoorn, PhD, Effie W Petersdorf, MD, Olle Ringdén, MD, PhD, Michelle Setterholm, Stephanie J. Lee, MD, MPH

Blood (2008) 112 (11): 563.

https://doi.org/10.1182/blood.V112.11.563.563

Published: 2008

Journal Articles

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

Stephanie J. Lee, John Klein, Michael Haagenson, Lee Ann Baxter-Lowe, Dennis L. Confer, Mary Eapen, Marcelo Fernandez-Vina, Neal Flomenberg, Mary Horowitz, Carolyn K. Hurley, Harriet Noreen, Machteld Oudshoorn, Effie Petersdorf, Michelle Setterholm, Stephen Spellman, Daniel Weisdorf, Thomas M. Williams, Claudio Anasetti

Blood (2007) 110 (13): 4576–4583.

https://doi.org/10.1182/blood-2007-06-097386

Published: 2007

Includes: Supplemental data

Journal Articles

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

Sarah Cooley, MD, Jeffrey S. Miller, MD, Elizabeth Trachtenberg, PhD, Tracy Bergemann, PhD, Koy Saeteurn, John Klein, PhD, Lisbeth A. Guethlein, Steven G.E. Marsh, PhD, Daniel Geraghty, PhD, Peter Parham, PhD, Daniel Weisdorf, MD

Blood (2007) 110 (11): 43.

https://doi.org/10.1182/blood.V110.11.43.43

Published: 2007

Journal Articles

The Detection of Donor-Directed, HLA-Specific Alloantibodies in Recipients of Unrelated Hematopoietic Cell Transplantation Is Predictive of Graft Failure.

Robert Bray, Sandy Rosen-Bronson, Michael Haagenson, John Klein, Susan Flesch, Cynthia Vierra-Green, Stephen Spellman, Claudio Anasetti

Blood (2007) 110 (11): 475.

https://doi.org/10.1182/blood.V110.11.475.475

Published: 2007

Journal Articles

Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.

Daniel J. Weisdorf, MD, Stephen Spellman, John Klein, PhD, Michael D. Haagenson, MS, Mary Horowitz, MD, Stephanie Lee, MD, MPH, Claudio Anasetti, MD, Michelle Setterholm, Rebecca Drexler, BS, AAS, Martin Maiers, Roberta King, Dennis Confer, MD

Blood (2007) 110 (11): 45.

https://doi.org/10.1182/blood.V110.11.45.45

Published: 2007

Journal Articles

HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation

Judith A. Wade, Carolyn Katovich Hurley, Steven K. Takemoto, John Thompson, Stella M. Davies, Thomas C. Fuller, Glenn Rodey, Dennis L. Confer, Harriet Noreen, Michael Haagenson, Fangyu Kan, John Klein, Mary Eapen, Stephen Spellman, Craig Kollman

Blood (2007) 109 (9): 4064–4070.

https://doi.org/10.1182/blood-2006-06-032193

Published: 2007

Journal Articles

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

Jeffrey S. Miller, MD, Sarah Cooley, MD, Peter Parham, PhD, Michael R. Verneris, MD, Karina McQueen, Libby Guethlein, Sherif Farag, MD, Michael Haagenson, Mary Horowitz, MD, John Klein, PhD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 171.

https://doi.org/10.1182/blood.V108.11.171.171

Published: 2006

Journal Articles

Volunteer Unrelated Donor PBSC Collection Efficacy and Recipient Outcomes: Results of a Prospective National Marrow Donor Program (NMDP) Trial, 1999–2003.

Michael Pulsipher, Pintip Chitphakdithai, John Klein, Seira Kurian, Susan Leitman, Paolo Anderlini, Brent Logan, Mary M. Horowitz, Dennis L. Confer

Blood (2006) 108 (11): 169.

https://doi.org/10.1182/blood.V108.11.169.169

Published: 2006

Journal Articles

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

Stephanie J. Lee, MD, MPH, John Klein, PhD, Michael Haagenson, MS, Lee Ann Baxter-Lowe, PhD, Dennis Confer, MD, Mary Eapen, MBBS, Marcelo Fernandez-Vina, PhD, Neal Flomenberg, MD, Mary Horowitz, MD, Carolyn Hurley, PhD, Harriet Noreen, CHS, Machteld Oudshoorn, PhD, Effie Petersdorf, MD, Michelle Setterholm, MS, Stephen Spellman, MS, Daniel Weisdorf, MD, Thomas M. Williams, MD, Claudio Anasetti, MD

Blood (2006) 108 (11): 172.

https://doi.org/10.1182/blood.V108.11.172.172

Published: 2006

Journal Articles

Interleukin-1 α Genotype and Outcome of Unrelated Donor BMT for CML.

Parinda A. Mehta, MD, Mary Eapen, MBBS, Sharavi Gandham, MS, James Elliott, BS, MBA, Michelle Combs, BS, Tiffany Wilke, BS, Richard Aplenc, MD, Margaret L. MacMillan, MD, Daniel J. Weisdorf, MD, Effie W. Petersdorf, MD, John Klein, PhD, Stella M. Davies, MBBS PhD

Blood (2005) 106 (11): 2057.

https://doi.org/10.1182/blood.V106.11.2057.2057

Published: 2005

Journal Articles

Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Leukemia: Risks and Benefits of Umbilical Cord Blood (CB) vs. Bone Marrow (BM).

Pablo Rubinstein, MD, Mary Eapen, MBBS, Cladd Stevens, MD, Joanne Kurtzberg, MD, Andromachi Scaradavou, MD, John Klein, PhD, Mary Horowitz, MD, John Wagner, MD

Blood (2005) 106 (11): 302.

https://doi.org/10.1182/blood.V106.11.302.302

Published: 2005

Journal Articles

Higher Cell Dose and CD34+ Content Improves Engraftment Following Unrelated Donor Cord Blood Transplantation (CBT): A Report of the National Marrow Donor Program (NMDP) Cord Blood (CB) Experience.

Donna Wall, John Wagner, Mary Laughlin, Karen Ballen, Susan Staba, Ka Wah Chan, Olivia McGaha, Brent Logan, John Klein, Mukta Arora

Blood (2004) 104 (11): 975.

https://doi.org/10.1182/blood.V104.11.975.975

Published: 2004

Journal Articles

Superior survival associated with transplantation of matched unrelated versus one-antigen–mismatched unrelated or highly human leukocyte antigen– disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts

William R. Drobyski, John Klein, Neal Flomenberg, Daniel Pietryga, David H. Vesole, David A. Margolis, Carolyn A. Keever-Taylor

Blood (2002) 99 (3): 806–814.

https://doi.org/10.1182/blood.V99.3.806

Published: 2002

NARROW

The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

Identifying Amino Acid Substitution Positions Associated with Day 100 Survival in Unrelated Donor Stem Cell Transplant Using Random Forest Analysis

Donor-Recipient Matching at the HLA-C Locus and Early Outcomes after Unrelated Umbilical Cord Blood Transplant (UCBT)

The Clinical Significance of Matching for Alleles at the Low Expression HLA Loci DP, DQ and DRB3/4/5 in Unrelated Hematopoietic Stem Cell Transplantation

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

The Detection of Donor-Directed, HLA-Specific Alloantibodies in Recipients of Unrelated Hematopoietic Cell Transplantation Is Predictive of Graft Failure.

Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.

HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

Volunteer Unrelated Donor PBSC Collection Efficacy and Recipient Outcomes: Results of a Prospective National Marrow Donor Program (NMDP) Trial, 1999–2003.

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

Interleukin-1 α Genotype and Outcome of Unrelated Donor BMT for CML.

Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Leukemia: Risks and Benefits of Umbilical Cord Blood (CB) vs. Bone Marrow (BM).

Higher Cell Dose and CD34+ Content Improves Engraftment Following Unrelated Donor Cord Blood Transplantation (CBT): A Report of the National Marrow Donor Program (NMDP) Cord Blood (CB) Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only